Department of Dermatology, Bispebjerg Hospital, Copenhagen, Denmark.
Department of Biomedical Sciences, University of Copenhagen, Copenhagen, Denmark.
Int J Dermatol. 2017 Dec;56(12):1342-1348. doi: 10.1111/ijd.13668. Epub 2017 Jun 1.
Chronic urticaria is an itching skin disease which persists for more than 6 weeks. Chronic urticaria has great impact on the daily life of the patient, and the fluctuating nature of the symptoms complicates the monitoring and treatment of the disease. Currently, there are no reliable biomarkers to identify and measure disease activity in chronic spontaneous urticaria. Consequently, use of patient-reported outcomes (PROs) is crucial when evaluating and monitoring different aspects of chronic urticaria such as disease activity/severity, disease control, and quality of life. We present an overview of seven different PROs used in chronic urticaria and highlight their strengths, limitations, and use in clinical practice and research.
慢性荨麻疹是一种持续超过 6 周的瘙痒性皮肤病。慢性荨麻疹对患者的日常生活有很大影响,且症状的波动性使疾病的监测和治疗变得复杂。目前,尚无可靠的生物标志物来识别和衡量慢性自发性荨麻疹的疾病活动度。因此,在评估和监测慢性荨麻疹的不同方面(如疾病活动/严重程度、疾病控制和生活质量)时,使用患者报告的结局(PROs)至关重要。我们介绍了七种用于慢性荨麻疹的不同 PRO,并强调了它们的优势、局限性以及在临床实践和研究中的应用。